✦ LIBER ✦

RESULTS OF THE FEASIBILITY STAGE OF STAMPEDE: A MULTIARM, MULTI-STAGE PHASE II/III TRIAL FOR PATIENTS WITH HIGH RISK PROSTATE CANCER (ISRCTN78818544)

✍ Scribed by N.W. Clarke; M.R. Sydes; D. Dearnaley; M.D. Mason; R.C. Morgan; K. Sanders; J. Anderson; R. Popert; J. Masters; M. Parmar; N.D. James

Book ID: 119618978
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 69 KB
Volume: 7
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(08)60648-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4027 POSTER Results of the feasibility s

4027 POSTER Results of the feasibility stage of STAMPEDE: a Multi-Arm, Multi-Stage phase II/III trial in patients with high risk prostate cancer (MRC PR08, ISRCTN78818544)

✍ N.D. James; M.D. Mason; M.R. Sydes; K. Sanders; D.P. Dearnaley; J.B. Anderson; R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Feasibility of Radical Prostatectomy Aft

Feasibility of Radical Prostatectomy After Neoadjuvant Chemohormonal Therapy for Patients With High Risk or Locally Advanced Prostate Cancer: Results of a Phase I/II Study

✍ KONETY, BADRINATH R.; EASTHAM, JAMES A.; REUTER, VICTOR E.; SCARDINO, PETER T.; 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 72 KB

A randomized phase-III trial of docetaxe

A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer

✍ Keun Seok Lee; Jungsil Ro; Byung-Ho Nam; Eun Sook Lee; Youngmee Kwon; Hye Soo Kw 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 285 KB

6010 A three-arm phase III randomized tr

6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial

✍ Hoff, P.; Clarke, S.; Cunningham, D.; Van Cutsem, E.; Moore, M.; Schmoll, H.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

138 ADJUVANT MULTIMODALITY TREATMENT IN

138 ADJUVANT MULTIMODALITY TREATMENT IN PATIENTS WITH HIGH RISK PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE CLINICAL PHASE-II TRIAL

✍ A. Heidenreich; C. Ohlmann; D. Pfister; D. Thüer; U.H. Engelmann 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Adjuvant whole abdominal intensity modul

Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol

✍ Nathalie Rochet; Alexandra D Jensen; Florian Sterzing; Marc W Munter; Michael H 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 283 KB